BibTex format
@article{Gairing:2025:10.1016/j.jhepr.2024.101295,
author = {Gairing, SJ and Mildenberger, P and Gile, J and Artusa, F and Scheiner, B and Leyh, C and Lieb, S and Sinner, F and Joerg, V and Fruendt, T and Himmelsbach, V and Abedin, N and Sahin, C and Boettcher, K and Schuhbaur, J and Labuhn, S and Korolewicz, J and Fulgenzi, CAM and D'Alessio, A and Zanuso, V and Hucke, F and Roehlen, N and Ben, Khaled N and Ramadori, E and Mueller, L and Weinmann, A and Kloeckner, R and Galle, PR and Tran, NH and Venkatesh, SK and Teufel, A and Ebert, M and De, Toni EN and Waldschmidt, D-T and Marquardt, JU and Bettinger, D and Peck-Radosavljevic, M and Geier, A and Reiter, FP and Rimassa, L and Pinato, DJ and Roderburg, C and Ettrich, T and Bitzer, M and Scheble, V and Ehmer, U and Berres, M-L and Finkelmeier, F and Gonzalez-Carmona, MA and von, Felden J and Schulze, K and Venerito, M and van, Boemmel F and Jochheim, LS and Pinter, M and Mohr, R and Ilyas, SI and Schmidtmann, I and Foerster, F},
doi = {10.1016/j.jhepr.2024.101295},
journal = {JHEP REPORTS},
title = {Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab},
url = {http://dx.doi.org/10.1016/j.jhepr.2024.101295},
volume = {7},
year = {2025}
}
RIS format (EndNote, RefMan)
TY - JOUR
AU - Gairing,SJ
AU - Mildenberger,P
AU - Gile,J
AU - Artusa,F
AU - Scheiner,B
AU - Leyh,C
AU - Lieb,S
AU - Sinner,F
AU - Joerg,V
AU - Fruendt,T
AU - Himmelsbach,V
AU - Abedin,N
AU - Sahin,C
AU - Boettcher,K
AU - Schuhbaur,J
AU - Labuhn,S
AU - Korolewicz,J
AU - Fulgenzi,CAM
AU - D'Alessio,A
AU - Zanuso,V
AU - Hucke,F
AU - Roehlen,N
AU - Ben,Khaled N
AU - Ramadori,E
AU - Mueller,L
AU - Weinmann,A
AU - Kloeckner,R
AU - Galle,PR
AU - Tran,NH
AU - Venkatesh,SK
AU - Teufel,A
AU - Ebert,M
AU - De,Toni EN
AU - Waldschmidt,D-T
AU - Marquardt,JU
AU - Bettinger,D
AU - Peck-Radosavljevic,M
AU - Geier,A
AU - Reiter,FP
AU - Rimassa,L
AU - Pinato,DJ
AU - Roderburg,C
AU - Ettrich,T
AU - Bitzer,M
AU - Scheble,V
AU - Ehmer,U
AU - Berres,M-L
AU - Finkelmeier,F
AU - Gonzalez-Carmona,MA
AU - von,Felden J
AU - Schulze,K
AU - Venerito,M
AU - van,Boemmel F
AU - Jochheim,LS
AU - Pinter,M
AU - Mohr,R
AU - Ilyas,SI
AU - Schmidtmann,I
AU - Foerster,F
DO - 10.1016/j.jhepr.2024.101295
PY - 2025///
TI - Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
T2 - JHEP REPORTS
UR - http://dx.doi.org/10.1016/j.jhepr.2024.101295
VL - 7
ER -